查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1706165

2025年全球肺部给药设备市场报告

Pulmonary Drug Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年肺部给药装置市场规模将强劲成长。到 2029 年，这一数字将成长至 699.1 亿美元，复合年增长率为 7.1%。预测期内的成长可归因于对呼吸照护中个人化和精准医疗的需求不断增长、居家医疗服务和远端患者监护的扩展、对研发的投资不断增加以及对预防保健和早期疗育策略的日益关注。预测期内的关键趋势包括技术创新、向基于价值的护理模式和以患者为中心的方法的转变、将远端医疗和远端监控功能整合到呼吸护理平台、使用穿戴式装置和行动应用程式进行呼吸系统疾病的自我管理，以及采用 3D 列印和数位製造技术。

预计未来几年呼吸系统疾病的日益普及将推动肺部给药设备市场的成长。呼吸系统疾病是一种影响肺部和呼吸道并损害人体呼吸的疾病或状况。呼吸系统疾病盛行率的上升是由多种因素造成的，包括空气污染水平上升、吸烟率上升、都市化、气候变迁和人口老化。肺部给药装置透过将药物直接输送到肺部，在呼吸系统疾病的治疗中发挥重要作用。例如，2024 年 5 月，美国国家公共卫生机构疾病管制与预防中心 (CDC) 报告称，18 岁及以上成年人的目前气喘盛行率从 2021 年的 8.0% 上升到 2022 年的 8.7%。因此，呼吸系统疾病盛行率的上升预计将推动肺部给药设备市场的成长。

肺部给药设备市场的主要企业正在开发小容量雾化器等创新产品，以便透过先进的功能更好地服务客户。低容量雾化器 (SVN) 是医疗设备，用于将液体药物以气雾化的形式输送给患有气喘、慢性阻塞性肺病) 和囊肿纤维化等呼吸系统疾病的患者。例如，2024年5月，美国医疗保健公司Medline Industries, LP推出了Hudson RCI Turbo Mist小容量雾化器。这款革命性的设备旨在短短三分钟内完成药物治疗。这种创新的雾化器每分钟输送的药物量是标准雾化器的 2.5 倍，治疗时间缩短了约 70%。增加剂量可显着缩短治疗时间，从而优化患者吞吐量，并透过缩短治疗时间改善患者体验，从而使医疗保健提供者受益。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情和经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球肺部给药装置 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球肺部给药装置市场：成长率分析
  • 全球肺部给药设备市场表现：规模与成长，2019-2024
  • 全球肺部给药设备市场预测：规模与成长，2024-2029，2034
  • 肺部给药装置的全球总目标市场（TAM）

第六章市场区隔

  • 全球肺部给药设备市场（按产品类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 干粉吸入器（DPI）
  • 定量喷雾吸入器（MDI）
  • 喷雾器
  • 全球肺部给药设备市场应用、效能及预测（2019-2024、2024-2029、2034）
  • 气喘
  • 囊肿纤维化
  • 慢性阻塞性肺病
  • 其他的
  • 全球肺部给药设备市场（依分销管道、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 零售药局
  • 医院药房
  • 电子商务
  • 全球肺部给药设备市场、干粉吸入器（DPI）细分、按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 单剂量DPI
  • 多剂量DPI
  • 全球肺部给药设备市场、定量喷雾吸入器（MDI）细分、按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 含氯氟烃的MDI
  • HFA基MDI
  • 全球肺部给药设备市场、雾化器细分市场、类型、性能及预测（2019-2024 年、2024-2029 年、2034 年）
  • 喷射雾化器
  • 超音波雾化器
  • 网状雾化器

第七章 区域和国家分析

  • 全球肺部给药设备市场（按地区、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 全球肺部给药设备市场（依国家/地区划分）、绩效及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 肺部给药设备市场：竞争格局
  • 肺部给药装置市场：公司简介
    • Medtronic plc
    • Air Liquide SA
    • Becton Dickinson and Company
    • Koninklijke Philips NV
    • Medline Industries Inc.

第31章 其他大型创新企业

  • ResMed Inc.
  • Dragerwerk AG And Co. KGaA
  • Smiths Group plc
  • AptarGroup Inc.
  • Chiesi Farmaceutici SpA
  • Teleflex Incorporated
  • Masimo Corporation
  • Fisher And Paykel Healthcare Limited
  • Invacare Corporation
  • Vyaire Medical Inc.
  • Inogen Inc.
  • Drive DeVilbiss Healthcare Inc.
  • Hovione
  • Hamilton Medical AG
  • GaleMed Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年肺部给药设备市场：提供新机会的国家
  • 2029年肺部给药设备市场：细分市场将带来新机会
  • 2029年肺部给药设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r31038

Pulmonary drug delivery devices are inhalation devices designed to administer medications directly to the lungs. These devices enable targeted drug delivery for treating respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Additionally, pulmonary delivery allows for the systemic absorption of drugs such as insulin and pain medications.

The primary types of pulmonary drug delivery devices include dry powder inhalers, metered dose inhalers, and nebulizers. Dry powder inhalers dispense a measured dose of medication in a fine, dry powder form that the patient inhales directly into their lungs. These devices are used for conditions such as asthma, cystic fibrosis, chronic obstructive pulmonary disease, and others. They are distributed through channels such as retail pharmacies, hospital pharmacies, and e-commerce.

The pulmonary drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides pulmonary drug delivery devices market statistics, including the pulmonary drug delivery devices industry global market size, regional shares, competitors with pulmonary drug delivery devices market share, detailed pulmonary drug delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the pulmonary drug delivery devices industry. These pulmonary drug delivery devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pulmonary drug delivery devices market size has grown strongly in recent years. It will grow from $49.52 billion in 2024 to $53.21 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis, the growing aging population worldwide, rising awareness about the importance of respiratory health, expansion of healthcare expenditure in emerging economies, and increasing adoption of homecare settings for respiratory therapy.

The pulmonary drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $69.91 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to the growing demand for personalized and precision medicine in respiratory care, expansion of home healthcare services and remote patient monitoring, rising investments in research and development, and increasing focus on preventive healthcare and early intervention strategies. Major trends in the forecast period include technological innovations, the shift towards value-based care models and patient-centric approaches, the integration of telehealth and remote monitoring capabilities into respiratory therapy platforms, the utilization of wearables and mobile applications for self-management of respiratory conditions, and the adoption of 3D printing and digital manufacturing techniques.

The growing prevalence of respiratory disorders is expected to drive the growth of the pulmonary drug delivery devices market in the future. Respiratory disorders are diseases or conditions that affect the lungs and airways, impairing human respiration. The increasing prevalence of respiratory disorders is due to several factors, such as rising levels of air pollution, increased smoking rates, urbanization, climate change, and an aging population. Pulmonary drug delivery devices play a crucial role in treating respiratory disorders by enabling direct medication delivery to the lungs. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, reported that the prevalence of current asthma among adults aged 18 and over increased from 8.0% in 2021 to 8.7% in 2022. Thus, the rising prevalence of respiratory disorders is expected to drive the growth of the pulmonary drug delivery devices market.

Major companies in the pulmonary drug delivery devices market are developing innovative products, such as small-volume nebulizers, to better serve customers with advanced features. A small-volume nebulizer (SVN) is a medical device used to deliver liquid medication in the form of an aerosolized mist to patients with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. For instance, in May 2024, Medline Industries, LP, a US-based healthcare company, launched the Hudson RCI TurboMist small-volume nebulizer. This groundbreaking device is designed to deliver medication treatments quickly, in as little as three minutes. The innovative nebulizer can dispense 2.5 times more medication per minute compared to standard nebulizers, reducing treatment times by about 70%. This increase in medication delivery significantly reduces treatment times, benefiting healthcare providers by optimizing patient throughput and enhancing the patient experience by shortening the duration of therapy sessions.

In August 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed amount. Through this acquisition, Sandoz aims to strengthen its portfolio of respiratory medicines and improve patient access to high-quality, complex therapies. Coalesce Product Development Limited is a UK-based company that provides pulmonary drug delivery devices.

Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson and Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Dragerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Masimo Corporation, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc., Nidek Medical Products Inc.

North America was the largest region in the pulmonary drug delivery devices market in 2024. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pulmonary drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pulmonary drug delivery devices market consists of sales of jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pulmonary Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pulmonary drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pulmonary drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pulmonary drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Dry Powder Inhalers; Metered Dose Inhalers; Nebulizers
  • 2) By Application: Asthma; Cystic Fibrosis; Chronic Obstructive Pulmonary Disease; Other Applications
  • 3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; E-Commerce
  • Subsegments:
  • 1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs; Multi-Dose DPIs
  • 2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs; HFA-Based MDIs
  • 3) By Nebulizers: Jet Nebulizers; Ultrasonic Nebulizers; Mesh Nebulizers
  • Companies Mentioned: Medtronic plc; Air Liquide S.A.; Becton Dickinson and Company; Koninklijke Philips N.V.; Medline Industries Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pulmonary Drug Delivery Devices Market Characteristics

3. Pulmonary Drug Delivery Devices Market Trends And Strategies

4. Pulmonary Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pulmonary Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pulmonary Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pulmonary Drug Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Pulmonary Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pulmonary Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pulmonary Drug Delivery Devices Total Addressable Market (TAM)

6. Pulmonary Drug Delivery Devices Market Segmentation

  • 6.1. Global Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Nebulizers
  • 6.2. Global Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Asthma
  • Cystic Fibrosis
  • Chronic Obstructive Pulmonary Disease
  • Other Applications
  • 6.3. Global Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retail Pharmacies
  • Hospital Pharmacies
  • E-Commerce
  • 6.4. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Dry Powder Inhalers (DPIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose DPIs
  • Multi-Dose DPIs
  • 6.5. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Metered Dose Inhalers (MDIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CFC-Based MDIs
  • HFA-Based MDIs
  • 6.6. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Nebulizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Jet Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

7. Pulmonary Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Pulmonary Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pulmonary Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pulmonary Drug Delivery Devices Market

  • 8.1. Asia-Pacific Pulmonary Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pulmonary Drug Delivery Devices Market

  • 9.1. China Pulmonary Drug Delivery Devices Market Overview
  • 9.2. China Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pulmonary Drug Delivery Devices Market

  • 10.1. India Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pulmonary Drug Delivery Devices Market

  • 11.1. Japan Pulmonary Drug Delivery Devices Market Overview
  • 11.2. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pulmonary Drug Delivery Devices Market

  • 12.1. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pulmonary Drug Delivery Devices Market

  • 13.1. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pulmonary Drug Delivery Devices Market

  • 14.1. South Korea Pulmonary Drug Delivery Devices Market Overview
  • 14.2. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pulmonary Drug Delivery Devices Market

  • 15.1. Western Europe Pulmonary Drug Delivery Devices Market Overview
  • 15.2. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pulmonary Drug Delivery Devices Market

  • 16.1. UK Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pulmonary Drug Delivery Devices Market

  • 17.1. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pulmonary Drug Delivery Devices Market

  • 18.1. France Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pulmonary Drug Delivery Devices Market

  • 19.1. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pulmonary Drug Delivery Devices Market

  • 20.1. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pulmonary Drug Delivery Devices Market

  • 21.1. Eastern Europe Pulmonary Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pulmonary Drug Delivery Devices Market

  • 22.1. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pulmonary Drug Delivery Devices Market

  • 23.1. North America Pulmonary Drug Delivery Devices Market Overview
  • 23.2. North America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pulmonary Drug Delivery Devices Market

  • 24.1. USA Pulmonary Drug Delivery Devices Market Overview
  • 24.2. USA Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pulmonary Drug Delivery Devices Market

  • 25.1. Canada Pulmonary Drug Delivery Devices Market Overview
  • 25.2. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pulmonary Drug Delivery Devices Market

  • 26.1. South America Pulmonary Drug Delivery Devices Market Overview
  • 26.2. South America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pulmonary Drug Delivery Devices Market

  • 27.1. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pulmonary Drug Delivery Devices Market

  • 28.1. Middle East Pulmonary Drug Delivery Devices Market Overview
  • 28.2. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pulmonary Drug Delivery Devices Market

  • 29.1. Africa Pulmonary Drug Delivery Devices Market Overview
  • 29.2. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pulmonary Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Pulmonary Drug Delivery Devices Market Competitive Landscape
  • 30.2. Pulmonary Drug Delivery Devices Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Air Liquide S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pulmonary Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. ResMed Inc.
  • 31.2. Dragerwerk AG And Co. KGaA
  • 31.3. Smiths Group plc
  • 31.4. AptarGroup Inc.
  • 31.5. Chiesi Farmaceutici S.p.A.
  • 31.6. Teleflex Incorporated
  • 31.7. Masimo Corporation
  • 31.8. Fisher And Paykel Healthcare Limited
  • 31.9. Invacare Corporation
  • 31.10. Vyaire Medical Inc.
  • 31.11. Inogen Inc.
  • 31.12. Drive DeVilbiss Healthcare Inc.
  • 31.13. Hovione
  • 31.14. Hamilton Medical AG
  • 31.15. GaleMed Corporation

32. Global Pulmonary Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pulmonary Drug Delivery Devices Market

34. Recent Developments In The Pulmonary Drug Delivery Devices Market

35. Pulmonary Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Pulmonary Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Pulmonary Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Pulmonary Drug Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer